Several chemotherapeutic drugs have been reported to regulate the immune environment of cancers, among which cisplatin can selectively deplete granulocytic-MDSCs (G-MDSCs), thus maintaining the function of CD8+ T cells against cancer [93]. This evidence concerns the gene CD8A and cancer.